Lv41
530 积分 2023-06-06 加入
Real-world Experience with New Systemic Agents for Atopic Dermatitis in the Netherlands
42分钟前
求助中
Sotatercept and the Development of Pericardial Effusions
19天前
已完结
International Multi-Center Case Series of Gestational Dupilumab Exposure in the Treatment of Atopic Dermatitis: Maternal Complications and Fetal Outcomes
20天前
已完结
JAAD Game Changers: “Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study”
20天前
已完结
Long-term effectiveness and safety of dupilumab in severe asthma: A 5-year real-world multicenter study
21天前
已完结
Dupilumab in Atopic Dermatitis Linked to Reduced Irritable Bowel Syndrome Risk: A Real-World Cohort Study
21天前
已完结
Dupilumab Use in Eosinophilic Esophagitis: Analysis of the FDA Adverse Event Reporting System Database
21天前
已完结
Post‐Marketing Safety of Bimekizumab in Psoriasis Patients: Pharmacovigilance Data From FDA Adverse Event Reporting System
1个月前
已完结
Evaluating Outcomes of Live‐Attenuated Vaccine Administration in Pediatric Patients on Dupilumab for Atopic Dermatitis
1个月前
已完结
An ambispective, real-world multi-center study of DOstarlimab in patients with Recurrent or Advanced DNA mismatch repair deficient/microsatellite instability-high endometrial cancer (GEICO 120-R/DORA study)
1个月前
已关闭
皖公网安备34019202002308
